CJC-1295
Growth Hormone Releasing Hormone analog
Mechanism of Action
GHRH analog that binds pituitary GHRH receptors to amplify pulsatile GH secretion. The DAC variant extends half-life via albumin binding; the no-DAC variant mimics natural GH pulses.
Key Benefits
- Growth hormone pulse amplification
- Improved body composition and lean mass
- Fat loss
- Improved sleep quality and recovery
Dosing Protocol
Classically stacked with Ipamorelin for synergistic GH pulse amplification.
Ideal Candidates
GH optimization, body recomposition, recovery.
Side Effects & Safety
Water retention, head rush/flushing, injection site reactions, tingling.
Regulatory Status
RestrictedFDA Category 2 — on the do-not-compound list. Educational reference only.
Frequently asked
What is CJC-1295?+
CJC-1295 (Growth Hormone Releasing Hormone analog) is a peptide studied for gh stimulation and muscle growth. GHRH analog that binds pituitary GHRH receptors to amplify pulsatile GH secretion. The DAC variant extends half-life via albumin binding; the no-DAC variant mimics natural GH pulses.
What is the dosing protocol for CJC-1295?+
Literature commonly references 1 mg/wk (low) to 2 mg/wk (maintenance) via SubQ weekly, on a 16–24 weeks cycle. Educational reference only — a licensed Stackhaus Health provider sets any personalized protocol.
What is the regulatory status of CJC-1295?+
FDA Category 2 — on the do-not-compound list. Educational reference only.
Where can I access CJC-1295?+
Research-grade CJC-1295 is available through Stackhaus Research. For a personalized, provider-reviewed protocol, consult a licensed clinician through Stackhaus Health.
More in Muscle & Performance
Used in these stacks
CJC-1295 appears in 1 research protocol in the Stackhaus Academy library.